On Thursday’s episode of Mad Money, host Jim Cramer turned his focus to large-cap stocks that surged by $10 or more in a single day.
“You always wish you had a stock that went up 10 bucks in a day, and today we had a bunch of them. It’s a sign that there is a gigantic change afoot, possibly the beginning of something that can make you a lot of money.”
READ ALSO: Jim Cramer Weighed In on These 16 Stocks and 17 Stocks on Jim Cramer’s Radar.
Cramer laid out what he calls the “holy quadruple” for a stock to pull off such a move: it must beat both earnings and revenue estimates and raise guidance on both as well, and all four must be strong. He mentioned that the company should have “good news on the tariff front”. He also pointed to encouraging developments in currency, noting that with the dollar weakening, American companies could regain an edge after years of foreign currency manipulation.
Beyond external factors, Cramer stressed that companies must deal with internal weaknesses, whether it is fading products, copycats, or leapfrogging tech, the business has to adapt. He added that any problems from the prior quarter must be fixed. He also emphasized the importance of margin growth and said he is especially impressed by companies that make bold, eye-catching projections.
“Finally, we want to know that the company has figured out that we want growth, high growth, and then more growth, and we don’t want so-called safety… With earnings season in full swing, it’s time to check your stocks to see if they can fit the formula I just gave you… That checklist is actually pretty good. Took me all day.”
Our Methodology
For this article, we compiled a list of 14 stocks that were discussed by Jim Cramer during the episodes of Mad Money aired on July 17. We listed the stocks in the order that Cramer mentioned them. We also provided hedge fund sentiment for each stock as of the first quarter of 2025, which was taken from Insider Monkey’s database of 1,000 hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
Jim Cramer Shed Light on These 14 Stocks
14. Eli Lilly and Company (NYSE:LLY)
Number of Hedge Fund Holders: 119
Eli Lilly and Company (NYSE:LLY) is one of the stocks that Jim Cramer shed light on. While Cramer still backed the company, he did express uncertainty about its future as he stated:
“What I’m thinking, as someone who owns Eli Lilly for the Charitable Trust and who wishes I owned PepsiCo, is that there might be a short-term peak in the use of these drugs (GLP-1s). The Achilles heel of these drugs is that they’re too effective. At some point, you lose enough weight, and you might think you can stop taking them… Whatever the case, if Eli Lilly is going to break out from this level, it needs breakthroughs in new areas, heart, brain, that it just doesn’t have right now, or there has to be some new data that shows something else positive that the GLP-1 drugs can do.
And of course, it’s got to start coming in pill form because people are tired of taking needles. I still like the stock of Eli Lilly. We have a huge gain in this one for the Charitable Trust. We’re going to hang on to it for now. But PepsiCo’s breakout, a lack of Lilly’s breakthroughs, and a reminder that at one point we were thinking of buying the airlines because of these GLP-1 drugs means that I no longer feel as certain about Lilly’s future without science that says these drugs do a lot more than just control diabetes and make you lose some weight.”
Eli Lilly (NYSE:LLY) is engaged in the research, development, and sale of pharmaceutical products, including therapies for diabetes, cancer, autoimmune disorders, pain, and migraines.
13. Cameco Corporation (NYSE:CCJ)
Number of Hedge Fund Holders: 58
Cameco Corporation (NYSE:CCJ) is one of the stocks that Jim Cramer shed light on. A caller asked about the company during the lightning round, and Cramer stated:
“I like CCJ. It’s one of the stocks, it’s one of those, along with Oklo and the small form reactors too. I just think that this is a winner. What am I going to say? I am pro-nuke, and I think people should be in them.”
Cameco (NYSE:CCJ) supplies uranium for electricity generation through activities such as mining, refining, and conversion. Additionally, the company provides nuclear technology, equipment, and services to commercial utilities and government agencies. Meridian Contrarian Fund stated the following regarding Cameco Corporation (NYSE:CCJ) in its Q1 2025 investor letter:
“Cameco Corporation (NYSE:CCJ) is a global leader in the mining, fabrication, and refinement of uranium products for nuclear power plants around the world. We view the company as a best-in-class operator with world-leading reserves and a low-cost profile. Cameco had been out of favor for many years following the 2011 Fukushima nuclear disaster, but became increasingly attractive as global uranium production declined below demand. We invested in 2020, believing uranium prices would recover and that there was upside optionality in the potentially resurgent interest in nuclear power. While the stock performed strongly in 2024, it weakened in the quarter as uranium stocks had become tied to the power-hungry AI data center trade. As such, the stock’s volatility far exceeded its fundamentals. Our position was unchanged during the quarter as we continue to base our investment on a 5- to 10-year investment thesis.”
12. Advanced Micro Devices, Inc. (NASDAQ:AMD)
Number of Hedge Fund Holders: 97
Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the stocks that Jim Cramer shed light on. A caller asked if Cramer thinks CEO Lisa Su can take the company to a trillion-dollar market cap, and he replied:
“I don’t know, but it’s going in the right direction. I mean, they obviously have now good GPUs. There’s a GPU shortage everywhere. Stock’s had a real big run off the bottom. I do think it could have a pullback, but I do think that she’s got what it takes to be able to take that stock much higher.”
Advanced Micro Devices (NASDAQ:AMD) is a global semiconductor company that designs and supplies microprocessors, graphics cards, chipsets, and embedded processors. On June 9, Cramer remarked:
“So traders say if I can’t make money after Broadcom reporting a great quarter, the playbook says time to move into the lower quality, cheaper stocks that are less likely to disappoint or should never have been down to begin with. I understand the sentiment, but the problem is that these stocks have already rallied pretty hard, too…I saw some upgrades for AMD…. They’ve moved, especially AMD by the way, on speculation it might be involved with any China deal. Rare earth materials for us, AMD chips for them.
Now, this kind of rotation could be a good one. The stocks that are rallying are excellent. They may be just playing catch-up. It’s a heavily broadening out of the winners, right? Remember when it was just the Mag Seven? We’ve come a long distance, but what comes after this could be treacherous. I’ve seen the end of rallies, and they often take up the laggards last. After it happens, if we have good news, everything’s fine. However, if there’s any degradation in the numbers, it could get very ugly. Right now we’re fine… I’ve always liked AMD, as you know.”
11. ConocoPhillips (NYSE:COP)
Number of Hedge Fund Holders: 70
ConocoPhillips (NYSE:COP) is one of the stocks that Jim Cramer shed light on. When a caller asked about the company during the lightning round, Cramer commented:
“All right. Buy COP. Let me tell you, I just told Jeff Marks, my partner for the club, that we’re in the wrong one now. Coterra is not delivering. We should be in ConocoPhillips. I just said it today. I’m not going to say it behind… I tell it to you, I say it to him. That’s how I play it.”
ConocoPhillips (NYSE:COP) engages in the exploration, production, and transportation of crude oil, bitumen, natural gas, liquefied natural gas, and natural gas liquids. Earlier in June, when a caller expressed their wish to sell COP shares for LLY shares, Cramer replied:
“I like your idea. I like your idea. I like your idea. I think Lily’s at a great level, and Conoco is not nearly as all the oils go to like 4 or 5% yield, this is only three and a half. I want you to sell the Conoco and buy the Lilly. I like that idea.”
10. Centrus Energy Corp. (NYSE:LEU)
Number of Hedge Fund Holders: 23
Centrus Energy Corp. (NYSE:LEU) is one of the stocks that Jim Cramer shed light on. A caller inquired about the company during the episode, and here’s what Cramer had to say in response:
“Okay, and I know the company. Centrus Energy fits in this particular niche that I’ve been saying, along with Oklo. I am not going to go against anybody who wants to buy uranium or nuclear because it’s coming back. Do I think it’s going to come back within the time frame… That’s no longer necessary. We have a new kind of market. I believe… when you get the book that comes out at the end of September, How to Make Money in Any Market, you will see that I endorse having one speculative position in your portfolio. Make Centrus your speculative position, and I say you are on my team. You will make money in any market.”
Centrus Energy (NYSE:LEU) provides nuclear fuel components, including enriched uranium products and separative work units, to utilities operating nuclear power plants. The company also delivers technical, engineering, manufacturing, and operations services to both public and private sector clients.
9. Novo Nordisk A/S (NYSE:NVO)
Number of Hedge Fund Holders: 60
Novo Nordisk A/S (NYSE:NVO) is one of the stocks that Jim Cramer shed light on. A caller asked about the stock’s status, and Cramer replied:
“I want you to know I don’t want Novo Nordisk… and the reason that is because if there’s going to be talk about tariffs on foreign drugs versus Eli Lilly, Novo is going to have an even less of an edge on this thing. So I say Novo, we don’t need the bottom finish. It’s not for me.”
Novo Nordisk (NYSE:NVO) is engaged in the research, development, manufacturing, and distribution of pharmaceutical products. It is worth noting that when a caller asked Cramer if he thinks the stock is a buy in April, he said:
“I do…. It got low enough. When it hit 3.6% yield, it was low enough. Apparently, they’re doing exactly what President Trump wants. I am a buyer at this point in Novo Nordisk, though of course I do like Eli Lilly more, but this stock has come down enough.”
8. FLEX LNG Ltd. (NYSE:FLNG)
Number of Hedge Fund Holders: 9
FLEX LNG Ltd. (NYSE:FLNG) is one of the stocks that Jim Cramer shed light on. Praising the dividend payout, Cramer commented:
“… I was worried that it had a 3.4% dividend yield. And that seems big… Get this, I’m actually feeling pretty good about FLEX LNG. Looking at the numbers, the dividend feels safe to me, even if the company’s balance sheet is far from clean. Still, FLEX LNG’s dividend has remained constant at 75 cents per quarter since mid-2021… They consistently generate much more free cash flow than they need to pay the dividend…
So I think they’ll be fine, but I think the fact that it doesn’t have the money to cover right now is making people nervous. More important, FLEX LNG operates in an increasingly strong business. Almost all their natural gas transportation fleet is contracted out for several years into the future. So you know what? You’ve got my blessing. You can buy this one for the 13% yield, even if I don’t necessarily expect a higher share price given that profits have been steadily falling, not rising. Here’s the bottom line:… If you’re looking for a big dividend, you can do a lot worse than FLEX LNG.”
FLEX LNG (NYSE:FLNG) specializes in the marine transportation of liquefied natural gas to global markets.
7. Nutex Health Inc. (NASDAQ:NUTX)
Number of Hedge Fund Holders: 5
Nutex Health Inc. (NASDAQ:NUTX) is one of the stocks that Jim Cramer shed light on. While Cramer acknowledged that the company has an “interesting story,” he said:
“… Why is the stock coming in over the past couple of months? Well, after a modest pullback in late May, Nutex started pulling back hard in the first week of June, ultimately falling more than 27% that week. Towards the end of that week, an analyst at Benchmark wrote a note explaining that the pullback was because of Blue Cross Blue Shield of Georgia filing a lawsuit against two physician provider groups that are using that same arbitration process that Nutex has had so much success with.
Now, look, the lawsuit doesn’t involve Nutex, okay, but it’s possible the arbitration gravy train might be facing some additional scrutiny, and that’s why I’m reluctant to stick my neck out for this one. I have zero read on the lawsuit in Georgia, but the fact that Nutex’s success in this arbitration process has come so easily out of nowhere makes me worry that perhaps it could go just as easily away out of nowhere. Plus, they’ve already had two great quarters fueled by the process.
In two more quarters, they’ll be lapping the changes, and those tremendous growth numbers will indeed evaporate. At best, it’s a major one-time change that instantly made Nutex a lot more profitable. But given that the stock’s already… you know, just up gigantically, you might need a new catalyst if you want more upside… In the end, Nutex has an interesting story, but it sure feels like I missed it. How about that? Now, because we missed it, it’s risky.”
Nutex Health (NASDAQ:NUTX) is a physician-led healthcare company that manages micro-hospitals, specialty hospitals, and outpatient departments offering 24/7 care. The company provides emergency and inpatient services, behavioral health, diagnostic imaging, laboratory testing, pharmacy services, and administrative support to affiliated healthcare providers through a cloud-based platform.
6. Abbott Laboratories (NYSE:ABT)
Number of Hedge Fund Holders: 70
Abbott Laboratories (NYSE:ABT) is one of the stocks that Jim Cramer shed light on. Commenting on the company’s recent earnings report results, Cramer said:
“Today, in an otherwise positive market, I was discouraged to get a mixed update from Abbott Labs, medical technology company that we’ve long owned for the Charitable Trust… I’d say two decades. When Abbott Labs reported this morning, the… results were perfectly solid. Management tightened their full-year earnings guidance rather than raising it while also taking down their organic sales growth forecast and their operating margin outlook.
A lot of investors, including me, have been hoping they’d raise these numbers, so the stock got clobbered down more than $11 or 8.5%. I thought it might’ve been down $15. That’s what I predicted. It didn’t get that low. As I’ve chronicled many times, this is a stock where we’ve really had to battle over the past several quarters. We’ve kept our faith for the Charitable Trust during some nasty litigation last year. The stock bounced back from that.”
Abbott (NYSE:ABT) is a healthcare company engaged in the research, development, manufacture, and marketing of a wide range of medical products.
5. Costco Wholesale Corporation (NASDAQ:COST)
Number of Hedge Fund Holders: 93
Costco Wholesale Corporation (NASDAQ:COST) is one of the stocks that Jim Cramer shed light on. Noting that the stock is down from its highs, a caller asked if they should add to their position or wait for tariff updates. Cramer replied:
“No, look, here’s the problem with Costco: It is a victim of its own success. All it really does is ever go up and then has these periods where it languishes. We’re in the languish period. That’s when you buy Costco. Do I think Costco’s in trouble at 50 times earnings? Are you kidding me? I think Costco’s, I still think Costco may be… one of the top five companies of all time. That is no slight to Jensen Huang because he’s number one.”
Costco (NASDAQ:COST) operates a membership-based warehouse model. The company provides a selection of brand-name and private-label products in bulk at reduced prices through this structure. On July 10, Cramer extensively commented on the company and stock as he said:
“There was a lot of talk about Costco, same store sales, not great… Costco, which reported June monthly sales last night after the close, delivered 5.5% US comparable sales growth, ex gasoline, when the Street was looking for a 6. Woo, disappointing, right? How disappointing? How about enough to send the stock down almost 12 points today? Is that wrong or is that right? I think it’s wrong. I like Costco, the store, very much, and I’m always looking for a chance to buy Costco, the stock, on weakness for the Charitable Trust… And boy is it ever tempting if we didn’t own so much Costco already to do some buying.
Why? Well, Costco’s been a long-time position of the trust because I love to shop there, and I love the business model where the company offers a limited number of goods at ultra-low prices and makes its money on your membership dues. The most articulate defender of Costco was the late Charlie Munger, Warren Buffett’s right-hand man on the board of Berkshire Hathaway… To me, Costco’s hundred-point discount from its high is about as good as you’re going to get.
JPMorgan, which has a Buy on the stock, says that Costco has been a ‘source of funds for big institutions of late,’ but they think that’s about to come to an end as the year-over-year comparisons are going to get easier. Now go back to what I said about how much of Wall Street acts like there’s never a good time to buy these high-quality stocks.
I think the truth is the opposite. There’s always a good time to buy shares in a great company, and it’s when the conventional wisdom says that a 5.5% same-store sales number, much better than almost any other company I follow, is somehow a real shortfall. I think Costco’s an amazing company, and this is the kind of buying opportunity that just doesn’t come along very often.”
4. Johnson & Johnson (NYSE:JNJ)
Number of Hedge Fund Holders: 91
Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer shed light on. Cramer was incredibly bullish on the company as he said:
“Now, sometimes in this game, you do just get lucky. You’ll come across a surprise quarter that tells you everything you need to know about what can cause a big cap stock to rally 10 points in a session. You’ll see how a star is born and even get a blueprint for what you need, what you should be looking for. Yesterday, we got a beautiful schematic from none other than Johnson & Johnson… which handed you a 10-point victory for the ages… This company put on a clinic that showed you exactly how you can orchestrate such a big gain… What does it take? Surprises, many surprises, that’s what…
… So, what did J&J have going for it?… Point blank, you got the holy quadruple. That’s J&J beating sales and earnings estimates for the quarter and then raising their sales and earnings guidance for the future… J&J raised its full-year reported sales guidance by $2 billion to midpoint, its earnings per share guidance by 25 cents. That’s just a monster set of numbers for a company whose stock has been languishing.
In the case of the pharmaceutical industry, you need to show some breakthroughs. J&J revealed some results of a 5-year trial that showed how their multiple myeloma immunotherapy is bringing a real-life-saving hope to patients suffering from this horrendous form of cancer…
J&J had previously put out some very high estimates for the cost of tariffs, and they took them down dramatically. You know what? That made me feel terrific because there are too many companies that are going to have to raise their tariff estimates, which will crush their stocks. For J&J, they cut their tariff forecast from $400 million down to 200 million. I’m calling that better than a sharp stick in the eye…
The bottom line: Check your stocks. Do they have a chance to change their stripes like J&J? Do they fit the formula? Remember, J&J is just beginning its move. Then you know what? You may be just sitting on, say it with me, a gold mine.”
Johnson & Johnson (NYSE:JNJ) develops, manufactures, and sells healthcare products, including prescription treatments across areas such as immunology, oncology, neuroscience, and cardiovascular disease, along with medical technologies used in surgery, orthopaedics, cardiovascular care, and vision correction.
3. Parker-Hannifin Corporation (NYSE:PH)
Number of Hedge Fund Holders: 51
Parker-Hannifin Corporation (NYSE:PH) is one of the stocks that Jim Cramer shed light on. PH stock was another stock that went up more than $10 in a single session and received a comment from Cramer during the episode. He remarked:
“We saw Eaton and Parker-Hannifin. If you’re from the Midwest, these are destination places… but those are a function of strong data center orders that came from lead contractors ABB and Legrand, two European construction companies that just reported that are huge builders of these warehouses full of servers. There’s no doubt that the data center buildout is the single biggest construction boom, perhaps since World War II. You can see it if you look at Oracle every day, by the way. I like the buildout. There are many many orders coming to them. I keep telling you these stocks are good. Parker-Hannifin rose $13.”
Parker-Hannifin (NYSE:PH) designs and supplies motion and control technologies. The company provides a wide range of components and systems used in industrial, mobile, and aerospace applications. Its products include sealing solutions, pumps, valves, actuators, filtration systems, fluid conveyance technologies, braking systems, and flight control equipment.
2. Eaton Corporation plc (NYSE:ETN)
Number of Hedge Fund Holders: 85
Eaton Corporation plc (NYSE:ETN) is one of the stocks that Jim Cramer shed light on. Coming to the company, Cramer commented:
“We saw Eaton and Parker-Hannifin. If you’re from the Midwest, these are destination places… but those are a function of strong data center orders that came from lead contractors ABB and Legrand, two European construction companies that just reported that are huge builders of these warehouses full of servers. There’s no doubt that the data center buildout is the single biggest construction boom, perhaps since World War II. You can see it if you look at Oracle every day, by the way. I like the buildout. There are many many orders coming to them. I keep telling you these stocks are good… Eaton jumped more than $17 or nearly 5% as investing club holders know. That Eaton move turned my earnings season around because it’s a core position in my Charitable Trust.”
Eaton (NYSE:ETN) is a power management company that provides a broad range of electrical, aerospace, and vehicle components and systems, including power distribution products, hydraulic equipment, aircraft systems, and vehicle drivetrain and power technologies. Carillon Tower Advisers stated the following regarding Eaton Corporation plc (NYSE:ETN) in its Q1 2025 investor letter:
“Pressure on Eaton Corporation plc (NYSE:ETN) shares stemmed from concerns about the possibility that reduced capital spending in the data center market could affect the entire AI supply chain. As a critical supplier of power connection products, the company’s multi-year growth prospects are affected by overall data center capital spending trends that continue to be favorable.”
1. PepsiCo, Inc. (NASDAQ:PEP)
Number of Hedge Fund Holders: 71
PepsiCo, Inc. (NASDAQ:PEP) is one of the stocks that Jim Cramer shed light on. Discussing large-cap stocks that went up 10 bucks in a single session, Cramer mentioned the company during the episode, as he said:
“First, the good news. These gains are anything but isolated. We’re getting a bunch of them each day. Today, we saw PepsiCo soar about 10 bucks. PepsiCo. Why? Better than expected numbers, of course, a turn in the fortunes of unhealthy foods, better executions, and a look of a variety of different products. PepsiCo isn’t some tiny micro-cap stock. It’s not like some meme cyber player or uranium bottle rocket, and it is not part of the Palantir empire. They probably have something in your fridge or your pantry. Take that, Palantir.”
PepsiCo, Inc. (NASDAQ:PEP) operates as a major producer, marketer, and distributor of a diverse portfolio of beverage and snack products. The company’s brand lineup includes Lay’s, Gatorade, Pepsi, Doritos, Tropicana, and Aquafina.
While we acknowledge the potential of PepsiCo, Inc. (NASDAQ:PEP) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PEP and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
